Manufacturing of high quality cell and gene therapy products

SCTbio offers its partners the highest quality services by delivering an engaging, methodical, and cost-effective approach to GMP manufacturing, quality control, process development and logistics services for your cell and gene therapy and viral vector manufacturing needs.

Why Starting Material Quality Makes or Breaks Your Cell Therapy

Why Starting Material Quality Makes or Breaks Your Cell Therapy

Swiss Biotech Days

5 Critical Lessons from Takeda's Cell Therapy Manufacturing Journey

5 Critical Lessons from Takeda's Cell Therapy Manufacturing Journey

Cell & Gene on the Med

April 15 - 17, 2025, Roma

German Biotech Days

April 9 - April 10, 2025, Heidelberg Congress Center, Berlin

Advanced Therapies Congress, London

March 18-19, 2025 at ExCel, London

SCTbio and CCRM Nordic Form Strategic Partnership to Accelerate Advanced Therapy Development

Driving the Future: Emerging Infrastructure and Technologies Revolutionizing Cell Therapy Logistics

Driving the Future: Emerging Infrastructure and Technologies Revolutionizing Cell Therapy Logistics

SCTbio Expands into the U.S. Market

New FDA Guidance Impacts the CAR-T Industry

SCTbio Brochure

SCTbio Your Reliable Partner for Cell & Gene Therapy GMP Manufacturing

SCTbio Brochure for Analytical Services

Check-out SCTbio full range of analytical capabilities!

Certificate of GMP Compliance

CIR Certification from the Government of France

Validation and Comparability of the BACTEC method & BD FX40 Device for Sterility Testing of CAR-T Drug Products: A Comprehensive Study

Validating BD BACTEC FX40 Method for CAR-T Sterility Testing

SCTbio and Cyto-care Collaborate to Improve Cell Therapy Cryopreservation and Logistics Capabilities in Europe

Source: Press Release - Prague, Czech Republic and Vienna, Austria

Orgenesis Announces Collaboration Agreement with SCTbio for the Production of Lentivirus Vectors

Source: Press Release - Germantown, MD and Prague, Czech Republic

SCTbio Video

Take a tour of our GMP manufacturing facility in Prague.

Change of company name: SOTIO a.s. is now SCTbio a.s.

Company split

Ukázka článku - Media

Praesent nec arcu lorem. Nulla vitae malesuada nisl, nec laoreet enim. Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Cambridge

SOTIO, LLC
200 Cambridgepark Drive, Suite 3100,
Cambridge, MA 02140
USA

Prague

SCTbio a.s.
Jankovcova 2,
170 00 Prague 7
Czech Republic

Bejing

SCTbio a.s.
Jankovcova 2,
170 00 Prague 7
Czech Republic

Manufacturing of high quality cell and gene therapy products

SCTbio offers its partners the highest quality services by delivering an engaging, methodical, and cost-effective approach to GMP manufacturing, quality control, process development and logistics services for your cell and gene therapy and viral vector manufacturing needs.

Manufacturing of high quality cell and gene therapy products

SCTbio offers its partners the highest quality services by delivering an engaging, methodical, and cost-effective approach to GMP manufacturing, quality control, process development and logistics services for your cell and gene therapy and viral vector manufacturing needs.

Leading engine
for the field of cell
and gene therapy

SCTbio is a stand-alone contract manufacturing organization offering full GMP services covering production of Advanced Therapy Medicinal Products (ATMPs) including genetically modified and viral vectors.  It is a part of PPF Biotech network. The  SCTbio mission is to serve as the leading engine for the rapidly advancing field of cell and gene therapy by offering a superior approach to GMP manufacturing for its partners. 

Services


SCTbio offers its capacities in the GMP manufacturing facility in Prague. The SCTbio expert team is available to manage technology transfers of products in any stage of preclinical/clinical development and to accommodate it to high cGMP standards.

Cell and gene therapy researchers working in SCTbio’s GMP laboratory.
Lab technician working at a microplate reader in SCTbio’s cell and gene facility.
Lab employees in full personal protective equipment handling cell and gene therapy products.
Employee loading up a cardboard box of biologic samples at SCTbio’s contract manufacturing facility.
Cell and gene therapy samples in a box.
Calculator and office equipment on some paper at SCTbio offices in Prague.

Facilities


SCTbio is proud to be a global organization, operating facilities in two continents which include GMP cell therapy manufacturing facilities in Prague, Czech Republic and Beijing, China. SCTbio has also access to a viral vector manufacturing facility operated by its affiliated company based in Cambridge, MA, USA.  

Cambridge

SOTIO, LLC
200 Cambridgepark Drive, Suite 3100,
Cambridge, MA 02140
USA

Prague

SCTbio a.s.
Jankovcova 2,
170 00 Prague 7
Czech Republic

Bejing

Manufacturing Facility SCTbio
Beijing Economic-Technological Dev. Area,
99 Kechuang 14, 30-B,
Beijing 100176, China